MediWound (MDWD) Net Income towards Common Stockholders (2013 - 2025)

MediWound's Net Income towards Common Stockholders history runs 13 years deep, the most recent figure standing at -$7.7 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders fell 27.03% year-over-year to -$7.7 million; the TTM figure through Dec 2025 stood at -$32.7 million (down 54.34% YoY), while the FY2025 annual figure was -$23.5 million, up 21.8% from the prior year.
• Net Income towards Common Stockholders was -$7.7 million for Q4 2025 at MediWound, down from -$6.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $940000.0 in Q2 2023 to a low of -$13.2 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged -$4.7 million across 5 years, with a median of -$4.2 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Net Income towards Common Stockholders sank 138300.0% in 2021, then jumped 121.63% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$4.2 million in 2021, then plunged by 76.47% to -$7.3 million in 2022, then jumped by 79.49% to -$1.5 million in 2023, then sank by 304.72% to -$6.1 million in 2024, then slipped by 27.03% to -$7.7 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$7.7 million (Q4 2025), -$6.5 million (Q3 2025), and -$13.2 million (Q2 2025), per Business Quant data.